This company has been acquired
Marrone Bio Innovations Balance Sheet Health
Financial Health criteria checks 2/6
Key information
139.3%
Debt to equity ratio
US$31.87m
Debt
Interest coverage ratio | n/a |
Cash | US$9.36m |
Equity | US$22.87m |
Total liabilities | US$53.34m |
Total assets | US$76.21m |
Recent financial health updates
Is Marrone Bio Innovations (NASDAQ:MBII) Using Too Much Debt?
Mar 13Does Marrone Bio Innovations (NASDAQ:MBII) Have A Healthy Balance Sheet?
Dec 09Recent updates
Marrone Bio Innovations shareholders approve merger deal with Bioceres Crop Solutions
Jul 11Time To Worry? Analysts Are Downgrading Their Marrone Bio Innovations, Inc. (NASDAQ:MBII) Outlook
Aug 21Marrone Bio Innovations, Inc. (NASDAQ:MBII) Is Expected To Breakeven In The Near Future
Apr 08Is Marrone Bio Innovations (NASDAQ:MBII) Using Too Much Debt?
Mar 13What Kind Of Investors Own Most Of Marrone Bio Innovations, Inc. (NASDAQ:MBII)?
Feb 15Marrone Bio Innovations (NASDAQ:MBII) Shareholders Have Enjoyed A 75% Share Price Gain
Jan 25When Will Marrone Bio Innovations, Inc. (NASDAQ:MBII) Turn A Profit?
Jan 04Does Marrone Bio Innovations (NASDAQ:MBII) Have A Healthy Balance Sheet?
Dec 09Marrone Bio Innovations, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 10Financial Position Analysis
Short Term Liabilities: MBII's short term assets ($33.0M) do not cover its short term liabilities ($41.7M).
Long Term Liabilities: MBII's short term assets ($33.0M) exceed its long term liabilities ($11.6M).
Debt to Equity History and Analysis
Debt Level: MBII's net debt to equity ratio (98.4%) is considered high.
Reducing Debt: MBII had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MBII has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: MBII has less than a year of cash runway if free cash flow continues to grow at historical rates of 11.3% each year.